Latest AI and machine learning research in other cancers for healthcare professionals.
PURPOSE: Several biomarkers of response to immune checkpoint inhibitors (ICI) show potential but are...
Most models for predicting malignant pancreatic intraductal papillary mucinous neoplasms were develo...
Non-invasive ischemic cancer therapy requires reduced blood flow whereas drug delivery and radiation...
OBJECTIVE: Mortality following surgical resection of spinal tumors is a devastating outcome. Naïve B...
Recent advances in artificial intelligence, particularly in the field of deep learning, have enabled...
OBJECTIVE: Muscle atrophy is associated with autologous stem cell transplantation (ASCT)-related out...
OBJECTIVE: To assess the capacity of support vector machine (SVM) algorithms that are developed base...
A brain tumor is an uncontrolled growth of cancerous cells in the brain. Accurate segmentation and c...
There can be significant uncertainty when identifying cervical lymph node (LN) metastases in patient...
Positron emission tomography (PET)/computed tomography (CT) are nuclear diagnostic imaging modalitie...
Image-guided surgery (IGS) allows for accurate, real-time localization of subsurface critical struc...
INTRODUCTION: Our markerless tumor tracking algorithm requires 4DCT data to train models. 4DCT canno...
Pre-treatment determination of renal cell carcinoma aggressiveness may help guide clinical decision-...
BACKGROUND: SymptomGuide Dementia (DGI Clinical Inc) is a publicly available online symptom tracking...
Complete resection of the tumor is important for survival in glioma patients. Even if the gross tota...
INTRODUCTION: The collision of medullary (MTC) and papillary thyroid carcinoma (PTC) in the same cer...
PURPOSE: This study investigated deep learning models for automatic segmentation to support the deve...
Gleason score, a measure of prostate tumor differentiation, is the strongest predictor of lethal pro...
We hypothesized that, in discrimination between benign and malignant parotid gland tumors, high diag...
Given the complexity and diversity of the cancer genomics profiles, it is challenging to identify di...